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Jesús Pérez-Gild,e,*, Ilpo Vattulainena,b,f,** 
aDepartment of Physics, University of Helsinki, Helsinki, Finland  
bComputational Physics Laboratory, Tampere University, Tampere, Finland  
cInstitute of Organic Chemistry and Biochemistry, Czech Academy of Sciences, Prague 6, Czech Republic 
dDepartment of Biochemistry, Faculty of Biology, Complutense University of Madrid, Spain  
e”Hospital 12 Octubre" Research Institute, Madrid, Spain 
fMEMPHYS – Centre for Biomembrane Physics 
 
*Corresponding author, **Principal corresponding author 
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Abstract  
Surfactant protein B (SP-B) is essential in transferring surface-active phospholipids from 
membrane-based surfactant complexes into the alveolar air-liquid interface. This allows 
maintaining the mechanical stability of the surfactant film under high pressure at the end of 
expiration, therefore SP-B is crucial in lung function. Despite its necessity, the structure and 
the mechanism of lipid transfer by SP-B have remained poorly characterized. Earlier, we 
proposed higher order oligomerization of SP-B into ring-like supramolecular assemblies. In 
the present work, we used coarse-grained molecular dynamics simulations to elucidate how 
the ring-like oligomeric structure of SP-B determines its membrane binding and lipid transfer. 
In particular, we explored how SP-B interacts with specific surfactant lipids, and how 
consequently SP-B reorganizes its lipid environment to modulate the pulmonary surfactant 
structure and function. Based on these studies, there are specific lipid-protein interactions 
leading to perturbation and reorganization of pulmonary surfactant layers. Especially, we 
found compelling evidence that anionic phospholipids and cholesterol are needed or even 
crucial in the membrane binding and lipid transfer function of SP-B. Also, on the basis of the 
simulations, larger oligomers of SP-B catalyze lipid transfer between adjacent surfactant 
layers. Better understanding of the molecular mechanism of SP-B will help in the design of 
therapeutic SP-B-based preparations and novel treatments for fatal respiratory complications, 
such as the acute respiratory distress syndrome.  
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SP, surfactant protein; DPPC, dipalmitoylphosphatidylcholine; PC, phosphatidylcholine; PG, 
phosphatidylglycerol; LB, lamellar body; ARDS, acute respiratory distress syndrome; SRT, 
surfactant replacement therapy; SAPLIP, saposin-like protein; EM, electron microscopy; 
AFM, atomic force microscopy; CG, coarse-grained; MD, molecular dynamics; POPC, 
palmitoyloleoylphosphatidylcholine; POPG, palmitoyloleoylphosphatidylglycerol; PI, 
phosphatidylinositol; APL, area per lipid. 
 
1. Introduction 
Pulmonary surfactant (PSurf) is an essential lipid–protein complex that covers the alveolar 
epithelium and maintains the gas exchange interface at the respiratory surface. The main 
biophysical function of PSurf is to decrease the surface tension at the air–water interface, thus 
reducing the work needed for breathing and preventing alveolar collapse at exhalation [1]. 
The PSurf consists of approximately 80% of zwitterionic phospholipids, 10% of neutral lipids 
(mostly cholesterol (CHOL)), and 8–10% of hydrophobic and hydrophilic surfactant proteins 
(SPs) [1-3]. While the hydrophilic SPs (SP-A and SP-D) are mainly involved in the innate 
immune mechanisms in the alveoli [4-6], the hydrophobic surfactant proteins (SP-B and SP-
C) together with the surfactant lipids play crucial roles directly in the biophysical function of 
the PSurf [7]. The three most important biophysical properties of functional PSurf films are 
rapid adsorption to the air–water interface, efficient compression during exhalation, and 
efficient re-extension upon expansion during inhalation [1, 4, 8]. These qualities of the PSurf 
depend on the highly optimized interplay between different lipid species and the hydrophobic 
SPs [4, 7]. 
Saturated zwitterionic dipalmitoylphosphatidylcholine (DPPC) is the most abundant 
phospholipid in the PSurf (~40% by total mass) and is responsible for the efficient surface 
tension reduction property of the surfactant [7, 9, 10]. Unsaturated zwitterionic 
phosphatidylcholine (PC) and unsaturated anionic phospholipids, mostly 
phosphatidylglycerol (PG), make up a majority of the rest of the phospholipid fraction [1]. 
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The composition of the PSurf is highly regulated and optimized as to the proportions of 
surface-tension-lowering (saturated) and fluidizing (unsaturated) lipid components [11, 12]. 
Neither lipid type can alone support both the surface active and the fluidic nature of the PSurf 
at physiological temperatures [13]. Moreover, specific protein–lipid interactions between the 
lipids and SPs are required for efficient surfactant film formation and re-extension at the air–
water interface [4, 13, 14]. 
One of the key proteins of the pulmonary surfactant is the pulmonary surfactant protein B 
(SP-B) (see Fig. 1). This protein partitions to the disordered lipid phases while binding to the 
surface of PSurf bilayers and monolayers with a preference for interacting with anionic 
phospholipids, like PG [15-18]. It participates in the packaging and exocytosis of the PSurf in 
the form of tightly-packed lamellar bodies (LBs) from the ATII cells into the aqueous phase 
[19]. SP-B also catalyzes efficient transfer of lipids between membranes and surfactant 
monolayers. This way, it enhances packing and re-extension of the surface-active lipid species 
during the compression–expansion cycles of breathing, promoting the formation, adsorption, 
and stabilization of the PSurf film at the air–water interface [9, 12-14, 20-23]. As an essential 
component of the pulmonary surfactant complex, the complete lack of SP-B results in a lethal 
respiratory failure at birth [24, 25]. Partial deficiency or inactivation of SP-B has been also 
associated with severe respiratory pathologies such as acute respiratory distress syndrome 
(ARDS) [26-28]. Development of a functional, safe, and affordable synthetic alternative for 
the current animal-derived surfactants used in surfactant replacement therapy (SRT) [29] in 
the treatment of preterm neonates and ARDS patients depends on our understanding of the 
underlying mechanism of the function of SP-B and its derivatives. 
SP-B belongs to the saposin-like protein (SAPLIP) family, which consists of lipid-interacting 
proteins with diverse functions sharing a common fold [30]. SP-B is a highly hydrophobic, 
79-residue polypeptide chain with a molecular weight of 8.7 kDa and a net positive charge of 
7 [31, 32]. Like other SAPLIP members, SP-B contains three intra-chain disulfide bridges 
that stabilize its fold. In the airways, SP-B appears in dimeric form [33], in which the 
monomers are connected by an inter-chain disulfide bridge at C48 [32, 34]. The dimerization 
of SP-B is involved in its surface tension reduction function [33]. Although the atomistic 
structure and the molecular mechanism of SP-B remain elusive [31, 35], our recent studies 
[19, 35] have revealed higher-order SP-B oligomers consisting of several SP-B dimers. 
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To account for the higher order oligomerization of SP-B, we previously proposed a new 
structural model for SP-B: a supradimeric oligomer model with n-fold circular symmetry [19, 
35]. In this model, dimeric units of SP-B homology modeled based on the dimeric saposin B 
(PDB ID: 1N69, Fig. 1A) [36], another member of the SAPLIP family, are arranged in a ring 
shape allowing formation of the characteristic intra-chain disulfide bridge at C48 between the 
neighboring monomers. Such an SP-B dimer (Fig. 1B) modeled based on saposin B structure   
accommodates all three intra-chain disulfide bridges (C8–C77, C11–C71, and C35–C46) [34], 
but not the inter-chain disulfide bridge (C48) [34] characteristic to SP-B (Fig. 1C,D). A ring-
like multidimeric model, however, can conceivably contain the inter-chain disulfide bridge 
between the neighboring dimers. Additionally, each dimer in such multidimeric model can 
enclose a phospholipid molecule between the monomers forming a putative lipid binding 
pocket (Fig. 1B), similar to the one in the closed saposin B conformation [36]. Moreover, the 
hydrophobic lining of the central pore in the middle of the oligomer ring (Fig. 1G) suggests a 
potential mechanism for lipid transport through this channel [35]. 
 
Figure 1. The structures of SP-B used in this study are based on a homology model with 
saposin B. (A) Sequence alignment of SP-B and saposin B shows the identities of the most 
important residues in the SAPLIP fold. The alpha helical segments are shown as spirals. (B) 
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The functional dimer consists of two non-covalently bound SP-B monomers modeled based 
on the crystal structure of saposin B (PDB ID: 1N69). A POPE lipid docked into the putative 
lipid binding cavity is shown in liquorice (cyan). (C,D) The disulfide-bridged dimer is 
covalently attached at C48 (yellow). The N-terminal insertion sequence (N-term., SP-B1−7, 
brown), helix 1 (α1, SP-B8−22, purple), helix 2 (α2, SP-B26−35, pink), helix 3 (α3, SP-B42−63, 
light blue), and helix 4 (α4, SP-B68−74, cyan) are shown in the structure. The residues at the 
turn of the secondary structure (SP-B36−45) form the membrane-perturbing site, while the 
membrane-binding site consists of the N-terminal insertion sequence, helix 1, and the C-
terminal helix 4. (E) Positions of the specific residues discussed further in the text. (F) The 
SP-B hexamer has two main membrane-interacting interfaces: Principal Interface 1 has the 
membrane-perturbing sites rotated towards its respective membrane, while Principal Interface 
2 has the membrane-binding sites including the N- and C-termini of the dimeric subunits 
towards the membrane. (G) Hydrophobic residues (grey), positively (blue) and negatively 
(red) charged residues, aromatic residues (green), neutral residues (white), and cysteines 
(yellow) shown at the surface of the SP-B hexamer structure. 
The discovery of functional higher-order oligomers has led t  various hypotheses on the 
molecular mechanism of SP-B and the role of other surfactant components in its 
oligomerization. Olmeda et al. [35] suggested that two SP-B oligomer rings can bridge nearby 
PSurf membranes by forming a hydrophobic tube, which would facilitate rapid flow of 
surfactant lipids between the membranes through the hydrophobic central pore of the 
oligomers. In this way, SP-B is thought to function as a key protein to promote lipid transfer 
between the surfactant storage structures and the monolayer film, which covers the air–liquid 
interface at the surface of the alveoli [14]. The oligomerization state of SP-B is driven by the 
molecular composition of the lipid environment, and by the presence and amount of SP-C 
[28, 35, 37]. SP-B establishes selective interactions with anionic lipids [17, 18]. Specifically, 
PG has been suggested to facilitate the oligomerization of SP-B in membranes [35, 37], which 
enhances SP-B activity. Moreover, the lipid transfer activity of SP-B is disrupted by high 
amounts of CHOL [38, 39], but this effect is counteracted with the inclusion of SP-C. 
Meanwhile, SP-C has been shown to dissociate and modulate the oligomerization of SP-B by 
forming SP-B/SP-C complexes [37]. 
In this study, we investigated the functional and structural implications of supra-dimeric ring-
like oligomers of SP-B, and its structural units, namely, the “functional dimer” (Fig. 1B) and 
the “disulfide-bridged dimer” (Fig. 1C). We refer to the dimer formed by two SP-B 
monomers in a conformation akin to that of saposin-B and without the inter-chain disulfide 
bridge at C48, the “functional dimer”. Because the structure of the functional dimer is based 
on the saposin B structure, the hydrophobic interface between the monomers contains a 
putative lipid-binding pocket, and it can be in either an open or closed conformation based on 
the relative position of the monomers. We chose to concentrate on the closed conformation 
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that already encloses a phospholipid in the saposin B model [36]. The “disulfide-bridged 
dimer”, on the other hand, refers to the two neighboring chains in the supra-dimeric model 
that form a dimer-stabilizing interface containing C48, E51, and R52 (Fig. 1E). These dimers 
are covalently bonded at C48 and form the structural subunit of the supra-dimeric model. We 
note that the exact number of dimers in the multidimeric complex is not known [35, 37]. 
Originally, particles of SP-B consistent with this supramolecular organization were isolated 
from detergent-solubilized surfactant preparations and imaged by electron microscopy (EM) 
and atomic force microscopy (AFM) [35] and SP-B was suggested to organize into oligomers 
of diverse sizes [35]. We, therefore, initially generated supradimeric models with circular 
symmetry of a range of number dimers for this study. However, we focused on the hexameric 
models in our simulations for feasibility. The hexamers fit well into the EM density [35], 
being currently the best structural model for SP-B.   
We used extensive coarse-grained (CG) molecular dynamics (MD) simulations to explore the 
biophysical properties of SP-B that emerge from its higher-order oligomerization [19, 35], 
and to clarify how these properties are involved in the various biological functions of SP-B. 
Particular attention was paid to the protein–lipid interactions associated with the different 
oligomeric states of SP-B to clarify their role in the oligomerization and membrane binding of 
the protein complex. Since these research themes focus on molecular processes that take place 
on short time scales, computer simulations are here the method of choice. Previous studies 
have shown that biomolecular simulations can reveal new exciting phenomena and, besides, 
help to interpret existing experimental observations [40, 41]. In the context of pulmonary 
surfactant, previous biomolecular simulations have been successful in, e.g., describing the 
folding of lipid layers at the water-air interface during compressions and expansion, and in 
explaining how SP-B monomers and dimers mediate lipid flow between monolayers and 
bilayers [42-45]. 
Our results suggest two important lipid interaction sites in the structure of the SP-B hexamer. 
First, the N- and C-terminal hydrophobic and positively charged residues are essential for the 
formation of a functional membrane-binding mode. Meanwhile, the hydrophobic central pore 
of the SP-B ring is involved in the lipid transfer activity of SP-B. The SP-B hexamer features 
membrane-perturbing active sites, which cause lipid protrusion into the central pore of the 
SP-B ring. The resulting lipid neck suggests a new molecular mechanism for lipid transfer by 
SP-B. Finally, the results provide an explanation as to how the lipid composition of the PSurf 
affects the membrane binding and the activity of SP-B: in essence, PG and CHOL have a 
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cooperative effect, where PG interacts with the positively charged residues in the protein, and 
CHOL binds to specific high-affinity binding sites found in the structure of the SP-B 
hexamer. 
2. Results 
2.1. Membrane Binding Mode and Lipid–Protein Interactions of the Dimeric SP-B Units 
We first investigated the lipid–protein interactions in the functional (Fig. 1B) and disulfide-
bridged dimer (Fig. 1C) using lipid self-assembly simulations. In these simulations, the 
positions of the lipid molecules were initiated randomly, and they were allowed to assemble 
into membranous structures. The use of the standard MARTINI model [46-49] allows for a 
high-throughput simulation method to perform unbiased protein-membrane binding studies. 
These simulations helped us characterize possible membrane-binding modes of the dimer 
units and define important lipid-protein binding sites in the SP-B structure. We took 
advantage of this information in designing the membrane-binding simulations of the SP-B 
hexamer. A detailed description of the binding modes of the dimers is discussed in the 
Supporting Information (SI) (see section S2.1). Here, we only provide a brief description 
highlighting the most essential features. 
Our simulations revealed that the functional dimer (Fig. 1B) binds the membrane in two 
different peripheral (surface-bound) modes (Figs. S1, S2, and S3), whereas the disulfide-
bridged dimer (Fig. 1C) can be found embedded more deeply into the membrane (Fig. S4 and 
S5). In the first mode of the functional dimer, the hydrophobic and positively charged 
residues in the N-terminal insertion sequence (SP-B1-7), the amphiphilic helix 1 (SP-B8-22), 
and the C-terminus (SP-B63-79) interact with the head group region of the membrane. For 
simplicity, we named the interface of the functional dimer that interacts with the above-
mentioned regions the membrane-binding site (Fig. 1A). In this mode, W9 and the three 
positively charged residues on helix 1 (R12, K16, and R17) (see Fig. 1E) interact specifically 
with the membrane, especially with POPG (Fig. S3). In the second mode, the positively 
charged and hydrophobic residues in the bend between helices 2 and 3 (SP-B36-45) are 
involved in membrane binding. In this mode, the opening of the lipid binding cavity faces the 
membrane and the binding causes perturbation of the nearby lipid head groups and acyl 
chains (Fig. S1). Thus, we named this interface of the functional dimer the membrane-
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perturbing site (Fig. 1A). Furthermore, our simulations showed that the disulfide-bridged 
dimers can oligomerize on bilayers (Fig. S6), which causes large lipid protrusions. 
2.2. Membrane Binding Modes of the SP-B Hexamer  
To get an unbiased view of the possible lipid binding modes of the SP-B hexamer, we 
considered four different lipid compositions (Table S1) in lipid self-assembly simulations. 
These simulations result in a multitude of lipid structures. We focus here only on a subset of 
self-assembly simulations, which resulted in the formation of continuous bilayers as 
successful self-assembly attempts. In these simulations, SP-B hexamer binds the bilayers 
peripherally with lipids filling its central cavity, regardless of the lipid composition used. 
The SP-B hexamer binds the bilayers in two distinct orientations with different levels of 
interaction with the membrane: the parallel and the perpendicular mode (Figs. 2A and 2B, 
respectively). The parallel mode (Fig. 2A) engages the membrane-binding sites of all subunits 
of the hexamer to interact with the membrane simultaneously. In particular, the N-terminal 
residues of the protein interact with high propensity with the bilayer in this mode (Fig. 2C). In 
this mode, connection of different lipidic structures can be mediated by the hexamer (Fig. 
2A). On the other hand, in the perpendicular mode only a few subunits interact with the 
bilayers (Fig. 2B). This incomplete membrane association suggests the perpendicular mode as 
an intermediate state before full association in the parallel mode. In all simulations, the central 
pore of the SP-B hexamer is filled with lipids, which is indicated by the increased lipid 
contact occupancy of the residues close to the centre of the hexamer (Fig. 2C). 
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Figure 2. The membrane-binding modes and lipid-protein interactions in the SP-B hexamer. 
Representative snapshots with the hexamer in the (A) parallel and (B) perpendicular 
membrane-binding modes are shown. The snapshot in (A) also represents a configuration 
where the hexamer connects two lipidic structures, a bilayer and a micelle. (C) The lipid 
contact occupancy of each residue in the simulations. The contact occupancies are calculated 
from the self-assembly simulations performed with the PHYSIOL lipid composition 
(interaction cut-off 6 Å). The data are averaged over all monomeric units in the hexamer and 
all relevant simulations, the bars showing the standard deviation. The blue line shows the 
distance of each residue from the central pore to indicate its relative position in the hexamer. 
The lipid contact occupancy plot in Fig. 2C shows that the central pore, in particular, strongly 
supports lipid interactions in all lipid types. These interactions also include lipid insertion into 
the lipid-binding pockets in the functional dimers. These pockets can fully shield the 
phospholipid acyl chains from the polar aqueous environment as they are transferred through 
the protein. The simulations show that the lipids can be fully or partially enclosed in the 
cavity (Fig. S7). In the partial enclosure, either one acyl chain or the head group of a 
phospholipid is inside the lipid-binding cavity. CHOL appears as the most common lipid to 
occupy the lipid-binding cavity and the central cavity as a whole, and this holds for all lipid 
compositions (Fig. S8). Unlike phospholipids, which also interact with the N-terminal 
residues, CHOL interacts only with the central pore residues (Fig. 2C). This observation 
suggests that in SP-B, the lipid-binding cavity is not specific to phospholipids but can also 
bind CHOL (Fig. S8). 
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2.3. Effect of POPG on the Interaction of the SP-B Hexamer with Surfactant 
Membranes  
To study the effects of POPG on the binding mechanism and orientation of the SP-B 
hexamer, we simulated the spontaneous membrane adsorption of SP-B by initially placing it 
in the parallel orientation away from the bilayers with and without PG (PHYSIOL and NoPG 
lipid compositions, Table 1; see Methods–Bilayer Simulations). The NoPG composition, used 
as a control here, maintains the same ratio between saturated and unsaturated phospholipids as 
in the PHYSIOL composition. In this manner, all other membrane properties were kept 
largely constant, allowing us to explore the effect of electrostatic protein–lipid interactions on 
membrane binding. Our simulations showed that POPG has a substantial effect on the rate of 
adsorption, affinity for membrane binding, and the orientation of the SP-B hexamer on 
membranes. 
 
Figure 3. The rate of spontaneous membrane adsorption of SP-B. The number of contacts 
between the protein and the membrane is shown as a function of time for each simulation 
repeat for the PHYSIOL (top left) and NoPG (bottom left) lipid compositions. The average 
time required for the binding (1.68±0.41 μs (PHYSIOL) and 6.85±1.11 μs (NoPG), average ± 
SE) is indicated by vertical dashed lines. The bar plots show the number of simulations in 
which a certain number of dimers (1–3 out of 6) is bound to the membrane at the end of the 
simulations, calculated based on the average number of contacts during the last 500 ns of the 
simulations for the PHYSIOL (top right) and NoPG (bottom right) lipid compositions. 
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POPG affects the rate of adsorption and initial binding (Fig. 3) of the SP-B hexamer on PSurf 
membranes. Based on the binding of the first dimer with the membrane in 24 repeats per 
composition (40 s each repetition), adsorption to the PHYSIOL and NoPG bilayers takes on 
average 1.680.41 s and 6.851.11 s (standard error), respectively. Here, the comparison 
of the binding times is justified, since the protein is in all simulations initially in the same 
orientation and placed at the same distance (9 nm) away from both periodic images of the 
bilayer. Based on these results, the electrostatic interactions between SP-B and the anionic 
lipids (PHYSIOL) speed up the binding process roughly by a factor of four compared to a 
PG-free membrane (NoPG) when using the standard MARTINI force field [46, 48, 49]. 
 
Figure 4. The SP-B hexamer adsorbs to the surface of membranes. The lipid composition of 
the membrane affects the rate and the strength of membrane binding, with SP-B binding faster 
and stronger with membranes containing POPG. (A) In the NoPG lipid composition, the SP-B 
hexamer binds preferably with only one dimer to the bilayer. (B, C) In the PHYSIOL lipid 
composition, the SP-B hexamer binds with two or three dimers. The electrostatic interactions 
between the negatively charged lipids and the positively charged residues in the membrane- 
binding face of SP-B have a significant effect on the binding process. 
The PSurf lipid composition affects the membrane-binding strength of SP-B. Interestingly, 
the membrane-binding proceeds by sequential binding of functional dimers in a discrete 
manner as can be seen in the gradual step-wise increase in the number of contacts between the 
protein and the membrane lipids (Fig. 3). In the presence of PG, the hexamer can achieve 
binding with up to three dimeric units, with a majority of simulations ending with two dimers 
bound within the time scale of the simulations (Figs. 3 and 4). However, in the absence of PG, 
the protein binds with only one dimer, with only a few repeats capturing two-dimer binding 
(Fig. 3). The one-dimer-bound state results in the previously discussed perpendicular 
orientation of the protein (Fig. 4A). Overall, the number of membrane-bound dimers 
fluctuates during the course of the simulations. Although partial unbinding events do occur in 
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both lipid compositions, after the initial binding, SP-B never desorbs completely from the 
membrane surface. More partial unbinding events occur in the NoPG systems where the 
electrostatic interactions between SP-B and the membrane are not as significant as in the 
PHYSIOL composition. 
The perpendicular membrane binding mode of SP-B is an intermediate step before full 
attachment to PSurf membranes. Shorter simulations with the improved polarizable 
MARTINI water model [47] with PME electrostatics showed complete and successful SP-B 
membrane adsorption to be based on the parallel membrane binding mode (see discussion in 
Section S2.2 in the SI). The parallel membrane binding of the SP-B hexamer also promotes 
lipid protrusions into the central pore of the ring (Fig. S9). 
2.4. Interaction of SP-B Hexamers with Lipid Monolayers 
To get better insight to the molecular mechanism of SP-B at the air-water interface, we 
investigated how SP-B hexamers interact with lipid monolayers. To construct these systems, 
we took advantage of the information provided by the self-assembly and bilayer simulations 
discussed above. Accordingly, we placed the SP-B hexamer in the parallel orientation, 
sandwiching it between two monolayers (for details, see Methods–Monolayer Simulations). 
In all systems considered, the SP-B hexamer causes lateral reorganization of the surfactant 
lipids (Fig. 5 and S11–S15). The general trends are most clearly seen in the PHYSIOL lipid 
composition discussed below (Fig. 5). The simulations suggest that both POPG and CHOL 
have distinct, functionally relevant, high-affinity interaction sites in the SP-B hexamer. At the 
same time, DPPC or POPC do not show any specific preference for SP-B. However, as 
further discussed in the next section, the effect of the SP-B hexamer on the different 
surfactant lipid species depends on the overall lipid composition and the average area per lipid 
(APL) of the monolayers it is in contact with.  
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Figure 5. Lateral lipid reorganization in PSurf monolayers caused by the SP-B hexamer in the 
PHYSIOL lipid composition. The SP-B hexamer is in the middle of each image lying along 
the membrane plane (see POPG as an example). The two-dimensional scaled number 
densities for each lipid type are shown as heat maps. Results shown here have been averaged 
over 12 simulation repeats at the APL of 55.0 Å2, normalized by the relative lipid 
composition. The scale bar (upper left panel) equals to 5 nm. The position and average size of 
the SP-B hexamer (10.4 nm) are indicated by a dashed circle.    
POPG has two high-affinity interaction sites, one at the Principal Interface 1 and another at 
the Principal Interface 2 (Figs. 1F, 5).  The first high-affinity POPG interaction site in the 
structure of the SP-B hexamer is at the Principal Interface 1 (Figs. 5, S11). The positively 
charged R36 at the membrane-perturbing site generates a POPG interaction hot spot in and 
around the central pore of the ring structure. The acyl chains of POPG molecules face towards 
the center of the ring (Figs. 6C, S7). At the Principal Interface 2, POPGs are located around 
the membrane-binding sites of SP-B, or more precisely, mainly interacting with the positively 
charged N- and C-terminal residues in helix 1 (R12, K16, and R17) and helix 4 (R72) (Fig. 8). 
CHOL has two main high-affinity interaction sites at the Principal Interface 1 (Figs. 5 and 6). 
The first high-affinity interaction site is at the opening of the central pore of the SP-B 
hexamer ring (Fig. 6A) and the second one inside the lipid-binding cavities between the non-
covalently bound adjacent dimers (Fig. 6B). In the first interaction site CHOL occupies either 
the opening of the lipid-binding cavity of the functional dimers near the central pore, or the 
small groove formed between the helices of two covalently bound SP-B monomers in the 
central pore (Fig. 6A). The first CHOL-binding site is highly conserved in all the six dimers 
in the SP-B hexamer structure and is seen at the Principal Interface 1 in Fig. 5 as the six 
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highly conserved interaction sites in the center of the protein ring. In the second interaction 
site CHOL occupies the lipid-binding cavities (Fig. 6B) and at the same time blocks the 
cavity from other lipids. Preference for either high-affinity CHOL interaction site can change 
between the two states within the same simulation. 
The occupancy of the high-affinity CHOL interaction sites depends on the lipid composition, 
APL of the monolayers, and the conformation of the protein. The first high-affinity CHOL 
interaction site in the central pore can be seen in the PHYSIOL lipid composition at both 
studied APLs (Figs. 5, S11). At the lower APL of 55 Å
2
, CHOL is preferably in the central 
pore, whereas at 57.5 Å
2
 CHOL alternates more often between both interaction sites. Indeed, 
in the PHYSIOL lipid composition CHOL occupies interchangeably either of the high-affinity 
interaction sites, whereas in the NoPG lipid composition CHOL is found only in the second 
interaction site, that is, inside the lipid-binding cavities (Figs. S14–S15). In the PHYSIOL 
lipid composition, the combined effect of CHOL and POPG seems to result in more extensive 
monolayer perturbations (discussed in the next section), which we conclude to partly result 
from the small differences in the orientation of the dimers with respect to the monolayers that 
results from interactions with POPG. The first CHOL interaction site in the central pore is 
preferred with larger monolayer perturbations. 
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Figure 6. CHOL (blue) has two high-affinity interaction sites in the structure of the SP-B 
hexamer at the Principal Interface 1 shown in (A) and (B). (A) CHOL occupies the opening of 
the lipid-binding cavities or the crevice between the helices of two covalently bound SP-B 
monomers. (B) CHOL is inside the lipid-binding cavities of the SP-B hexamer in the second 
interaction site. (C) Phospholipids (POPG green, PCs cyan) tend to orient themselves with 
their headgroups (red) towards the R36 (magenta) near the entrance of the hydrophobic 
central pore. 
 
2.5. Perturbation of Lipid Monolayers by SP-B Hexamers 
The SP-B hexamer causes spontaneous perturbations and protrusion of lipids upon interaction 
of the Principal Interface 1 with the monolayer surface (Fig. 7). Lipids protrude from one of 
the monolayers into the hydrophobic central pore of the SP-B hexamer ring, forming a lipid 
neck largely spanning the SP-B hexamer. The monolayer perturbations occur only at the 
Principal Interface 1, where the previously discussed membrane-perturbing sites at the turn of 
the secondary structure (SP-B36-45) are in contact with the membrane surface (Fig. 1). The 
lipid perturbations depend on very small conformational changes in the protein structure upon 
membrane binding. The initial protrusion of lipids into the central pore occurs rapidly within 
the first 500 ns of the simulations after contact with the monolayer (Fig. 7D). The lipid neck 
that originates from these protrusions is not fully stable in the CG simulations. However, in 
complementary atomistic simulations (after fine-graining the present CG structures to 
atomistic resolution) we found the central cavity to be fully covered with lipids and the 
structure to remain stable (see the SI, Fig. S16).  
The extent of lipid protrusions into the central pore depends on the lipid composition and the 
APL of the monolayers (Fig. 7). The level of membrane binding of SP-B and the relative 
orientation of the membrane-perturbing sites at the Principal Interface 2 with respect to the 
membrane surface also depend on the lipid composition. SP-B-induced monolayer 
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perturbations are most significant in the PHYSIOL lipid composition, followed by the 
NoCHOL and NoPG compositions, respectively. POPG is the main cause for the notable 
change in the membrane binding and conformation of SP-B, thereby leading to the observed 
difference in the membrane-perturbing action of SP-B. In the PHYSIOL and NoCHOL lipid 
environments, the interaction of the positively charged membrane-binding residues of SP-B 
with POPG at the Principal Interface 2, and R36 on the other side, orients the dimers in the 
SP-B hexamer so that the membrane-perturbing sites at the Principal Interface 1 are in better 
contact with the lipids. This causes lipids to protrude into the central pore, and CHOL to bind 
into the high-affinity sites surrounding the inner edge of the central pore of the protein ring.  
The average lipid protrusion is largest in the APL of 55.0 Å
2
 PHYSIOL systems, reaching 
almost complete transfer of lipids through the central cavity of the protein in some of the 
systems (Fig. 7). Generally, the effect of the APL on SP-B-induced lipid protrusion is most 
significant in the PHYSIOL systems. At the same time, in the NoPG systems the difference in 
the APL (55.0 Å
2
 vs. 57.5 Å
2
) does not affect the extent of lipid protrusion, which remains 
minimal during the 25 s simulations. At 57.5 Å2 in the NoPG and NoCHOL systems, SP-B 
causes only small lipid perturbations.  
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Figure 7. SP-B hexamer causes perturbations in surfactant monolayers upon interaction. 
(A,B) Lipid protrusions are minor in the NoPG and NoCHOL lipid compositions, 
respectively. (C) In the PHYSIOL lipid composition, where both CHOL and POPG are 
included, SP-B causes large lipid protrusions that largely span the central cavity. (D) Average 
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lipid protrusion distances into the central pore of the SP-B hexamer in the PHYSIOL, 
NoCHOL, and NoPG lipid compositions at the APL of 55.0 and 57.5 Å2. 
3. Discussion 
The lipid self-assembly simulations with the SP-B hexamer show two main lipid binding 
orientations at the surface of bilayers. The unifying feature with these two lipid binding 
modes is the lipid-filled central cavity of the SP-B hexamer. Interestingly, the self-assembly 
simulations show that in the parallel mode, the protein can bridge a bilayer to a secondary 
lipid assembly, such as a micelle (Fig. 2A) or a small bilayer disc, by maintaining a 
continuous lipid phase between them. This feature is further supported by the original idea by 
Olmeda et al. [35] and Hobi et al. [14] that by binding membranes in the parallel mode, SP-B 
oligomers can connect lipidic structures and facilitate lipid transfer between them through its 
hydrophobic central pore. Previous computational studies have shown [43, 45, 50] the role of 
SP-B monomers and dimers in lipid transfer between lipid reservoirs and surfactant 
membranes through similar lipid necks. Furthermore, oligomerization of SP-B in the presence 
of POPG has been shown to further enhance its activity in lipid transfer [19]. Thus, the 
parallel membrane binding orientation of the SP-B hexamer would better fit the previous 
experimental and computational findings. 
SP-B is known to interact preferentially with anionic phospholipids, such as PG and 
phosphatidylinositol (PI) [17, 18]. Indeed, the large net positive charge (+84) of the SP-B 
hexamer can explain this behavior [38]. How these interactions take place at the molecular 
level remain unclear, though, as does also their role in the function of SP-B. Experiments 
have shown that anionic lipids, such as POPG, could be essential for the adoption of the 
oligomeric organization of SP-B on surfactant membranes [19]. Our results are in line with 
these previous findings and clearly show that the presence of PG has an important role in SP-
B interaction with the membrane, promoting and accelerating the binding of the protein, and 
allowing the sequential attachment of dimers, which would result in a proper orientation of 
the complex parallel to the membrane. 
The lipid self-assembly simulations of the SP-B hexamer result in two main membrane 
binding orientations, the perpendicular and parallel mode. We note that the simulations here 
with the standard MARTINI model do not systematically capture the formation of the fully 
parallel binding mode during the simulated 40 s. Still the propensity of SP-B turning 
towards the parallel membrane binding orientation in the PHYSIOL composition indicates 
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that limitations in the electrostatics of the standard MARTINI model may cause inconclusive 
results. To this end, we ran three extra repetitions of equivalent binding simulations utilizing 
the improved polarizable water model [47] for MARTINI with the new-PME parameters (see 
discussion in the SI and Figs. S9 and S10), since the combination of PME and the polarizable 
water model provide a proper description of long-range electrostatic interactions, including 
solvent screening. In these additional simulations, SP-B reached the parallel membrane 
binding orientation in all PHYSIOL systems (see Fig. S9). In the NoPG systems, SP-B did 
not bind to the membrane within the 2.5 s simulation, while in the PHYSIOL composition 
the binding was almost instant (see Fig. S10). Thus, we conclude that both the perpendicular 
and parallel membrane binding modes are present in the standard MARTINI simulations, as 
we see in the self-assembly systems. The proper description of long-range electrostatics is 
needed to reach the parallel mode within reasonable simulation time, and this difference 
stresses the importance of electrostatic interactions in the binding process. Given that the 
parallel membrane binding mode of SP-B is fully compatible with previous experimental 
observations [19, 35], and also consistent with both the lipid self-assembly and adsorption 
simulations, there is sufficient evidence to conclud  that the SP-B hexamer is found in PSurf 
membranes in the parallel binding orientation. The perpendicular binding occurs in the 
simulations as an intermediate state before full incorporation to the membrane surface. 
The positions of the most important lipid-binding residues at both Principal Interfaces are 
further elucidated in Fig. 8. In the present work, the high net charge of the Principal Interface 
2 causes lateral reorganization in the membrane and a high local concentration of POPG 
around the SP-B hexamer, similar to the enrichment of negatively charged lipids near the 
protein observed in experiments [17]. Furthermore, POPG displaces other phospholipids 
around the SP-B hexamer. The high affinity of POPG to the Principal Interface 2, that is the 
essential main experimentally observed membrane-binding face of SP-B [51-53], is evident in 
every system we explored with the PHYSIOL and NoCHOL lipid compositions (Figs. 5 and 
S11–S13). Furthermore, at the Principal Interface 1 R36 is the most important residue that 
binds with POPG. The biological function of R36 could be related to its high affinity to the 
anionic PSurf lipid species. Thus, R36 could dock the SP-B hexamer rings to a second 
membrane through electrostatic interactions with anionic lipids and thus allow the transfer of 
lipids between the interconnected surfactant membranes through the ring-like oligomer 
structure. 
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Experiments have shown [8, 10, 28] that elevated levels of CHOL may cause surfactant 
inhibition, while physiological levels of CHOL have no detrimental effects on the function of 
the PSurf or SP-B. Indeed, SP-B in the presence of CHOL has been shown to somehow 
improve the biophysical properties of the PSurf and its clinical replacements [54-56]. The 
potential interaction between SP-C and cholesterol in surfactant membranes has been 
previously addressed [39, 57-60], pointing to a potential role of this protein in ensuring a 
proper surfactant distribution and metabolism of cholesterol. A functional cooperation of this 
protein with SP-B in membranes containing cholesterol [61] has been reported. However, to 
our knowledge, our results provide the first indication of specific CHOL-binding sites in the 
functional structures of SP-B oligomers. These specific interactions could also be important 
for the activity of SP-B and should be further characterized in future studies.  
The fusogenic, lytic, and surface tension lowering functions of SP-B have been determined to 
be predominantly caused by the N-terminal half of the protein, which includes helices 1 and 2 
(SP-B8-22 and SP-B26-35, respectively) [51]. In the same study, the C-terminal half of SP-B 
with helices 3 and 4 (SP-B42-63 and SP-B68-74, respectively) had significantly lower activities 
in all of these functions. Our results indicate a possible fusogenic and/or lytic domain at the 
bend between helices 2 and 3 (SP-B36-45). In our simulations, this site is essential for the 
membrane-perturbing function of the SP-B hexamer. Moreover, our simulations captured 
membrane insertion of the disulfide-bridged dimers. The insertion and subsequent 
oligomerization of the disulfide-bridged SP-B dimers on surfactant membranes (Fig. S6) can 
potentially induce the formation of proteolipid pores or invaginations in bilayers observed in 
experiments [62, 63]. 
A recent study by Hobi et al. [14] suggested that the release of the surface-active 
phospholipids to the air–liquid interface would be driven by a high internal pressure of the 
lamellar bodies and activation of the protein upon contact with air. Similarly, the lateral 
surface pressure changes of the PSurf during the compression–expansion cycles of breathing 
have been suggested to promote reversible squeeze-out and re-extension of lipids mediated by 
SP-B [4, 9, 23]. Small alternating conformational transitions in the SP-B tertiary structure 
upon contact with the air–water interface [14, 35] or upon the changes in lateral surface 
pressure of the PSurf monolayer during the breathing cycle could activate SP-B oligomers. In 
this way, SP-B would allow rapid flow of lipids into the alveolar surface in the spreading and 
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re-extension phases and squeeze-out of lipids from the surface during sufficient compression 
(Fig. 8E). Our observed ability of SP-B hexamers to form lipid necks protruding from 
monolayers or bilayers could be also related with the reported ability of the protein to 
promote lipid phases with negative curvature in the presence of anionic phospholipids [64, 
65]. 
All in all, these results help to understand the molecular mechanism of SP-B oligomers in the 
transfer of surface-active phospholipids from PSurf membranes into the respiratory surface. 
Our results support a model in which SP-B activity in lipid transfer across the central cavity 
depends greatly on the monolayer compression associated with lateral pressure during the 
respiration cycle, and the changes in the conformation of the protein. Our results further 
suggest that the lipid transfer mediated by SP-B oligomers would occur specifically through 
the hydrophobic central pore (Fig. 8E). We note that in this study we only considered 
hexamers, and higher-order oligomers are likely to exhibit somewhat different properties for 
lipid transport and membrane-perturbing properties. A larger number of dimers would 
essentially allow for more orientational flexibility around the inter-chain disulfide bridge, and 
thus more deformability, shape variation, and asymmetry. Indeed, there may be a functional 
mixture of various oligomeric sizes as different oligomers with somewhat different properties 
can work in synergy. 
 
Figure 8. The main lipid interaction sites described in this study projected on the atomistic 
SP-B hexamer model, and a proposed lipid transfer model for the supradimeric SP-B 
oligomers in PSurf membranes. (A) The most important membrane binding residues with the 
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highest lipid contact occupancies (threshold 0.5, Fig. S8A) in the lipid self-assembly and 
monolayer simulations cover the membrane-binding sites and the central pore of the SP-B 
hexamer. (B,C) The identified CHOL-interacting residues, and the POPG-interacting 
residues, respectively, shown on the structure, and (D) the same residues listed. (E) Our 
results suggest that SP-B oligomers may bridge surfactant structures together through the 
hydrophobic central pore. Transfer of lipids would be mediated by the changes in the lateral 
pressure of the surfactant layers during compression–expansion cycles of the alveoli. The 
colors in (A,B,C) are set for hydrophobic residues (grey), positively (blue) and negatively 
(red) charged residues, aromatic residues (green), neutral residues (white), and cysteines 
(yellow). 
4. Conclusions 
Using extensive coarse-grained MD simulations, we investigated how the SP-B complex (in a 
number of oligomeric states) interacts with pulmonary surfactant membranes, and how the 
specific protein–lipid interactions associated with membrane binding are related to the 
molecular mechanism of its lipid transfer function. 
We found two potential conserved lipid interaction sites in the structure of the SP-B hexamer: 
the first corresponding to the membrane-binding residues located in the N-terminal half of 
SP-B, and the second one near the bend between helices 2 and 3 (SP-B36-45). The first lipid-
interaction site seems essential for the correct binding and orientation of the protein with the 
PSurf membranes through hydrophobic and electrostatic interactions of the membrane-
binding residues. The second lipid interaction site shows significant membrane-perturbing 
functions in the SP-B hexamer, which to our knowledge has not been demonstrated in 
previous studies. 
Our results indicate that in particular PG and CHOL have a significant role in the function 
and efficiency of SP-B. As to PG, it is relevant to first bring out that SP-B has a high net 
positive charge with many functionally essential positively charged membrane-binding 
residues that affect the activity of the SP-B hexamer by causing small changes in the binding 
orientation of the dimers with respect to the negatively charged PSurf membrane surface. 
Next, regarding cholesterol, our results suggest two novel high-affinity CHOL-binding sites 
in the structure of the SP-B hexamer. The position of the first CHOL-binding site is near the 
opening of the hydrophobic central pore, while the second one is inside the lipid-binding 
cavities of the SP-B hexamer. 
Based on our studies, we find that the SP-B hexamer induces formation of membrane 
perturbations in PSurf through the central pore of the oligomer ring. The lipid-binding 
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
 23 
cavities between the adjacent disulfide-bridged SP-B dimers are important for this mechanism 
as they can reversibly enclose lipids inside. Lipid protrusions through the central pore of the 
SP-B hexamer could facilitate the connection and rapid lipid transfer between different 
surfactant structures.  
5. Methods 
5.1. The SP-B Models and the Simulation Protocols  
All CG-MD simulations (described below) used in this study were initiated from the 
following atomistic models of different oligomeric states of SP-B. The description below 
regarding the construction of the SP-B model is illustrated in Fig. 1. 
The SP-B functional dimer models. The homology models f SP-B functional dimers were 
obtained as previously described [35]. As in the dimeric saposin B crystal structure (PDBID: 
1N69) [36] used as the template, the SP-B functional dimer is modeled in two conformations 
(open and closed), and features a lipid binding site between the monomers. In the simulations, 
we used the closed version of the dimer (see Section S2.1 in SI), which corresponds to the 
closed AB dimer of saposin B [36]. Further, there is reason to stress that while there are 
several possible templates in the saposin family, we decided to use 1N69 because SP-B is 
known to be functional as a dimer, 1N69 (unlike many other templates) describes the dimeric 
state, and it has been postulated that oligomerization of dimers is necessary for the ring-like 
supramolecular organization. 
The SP-B supradimeric oligomer models. The functional dimer homology model was 
subjected to symmetric rigid docking [66] using the Rosetta software suite [67] to generate 
the ring-shaped supradimeric oligomer models of various sizes that conform to the criteria 
proposed by Olmeda et al. [35]. Specifically, the higher order oligomer models were ensured 
to i) contain the SAPLIP-like functional dimer as a structural unit in an either open or closed 
conformation, ii) have an inter-dimeric interface that can accommodate an inter-chain 
disulfide bridge between C48 residues and salt-bridges between respective E51 and R52 
residues, and iii) have the putative lipid binding site of each functional dimer facing towards 
the center of the ring. 
The SP-B dimer homology models extracted from the Olmeda et al. oligomer models [35] 
were first relaxed using the fast-relax protocol [68]. Then, symmetric docking [66] was 
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performed with appropriate cyclic symmetry definitions for the desired number of dimers. 
During symmetric docking, the distances between neighboring C48 residues were restrained 
using the “flat harmonic” restraint type, with the center of restraint, the tolerance, and the 
width parameters set to 2.0 Å, 1.8 Å, and 0.5 Å/ √𝑅𝐸𝑈, where REU stands for the Rosetta 
Energy Unit. 
The models were later sorted based on their total score and filtered. Top scoring models were 
first clustered using Calibur [69]. The cluster centers that satisfied the conditions (ii) and (iii) 
based on visual inspection using VMD [70] were selected for the next steps. These structures 
were further subjected to the fast-relax protocol [68], where the intra- and inter-chain 
disulfide bridges were set explicitly to optimize the side chain geometries. In all stages of 
modeling, the talaris2014 score function [71] was employed. 
The exact number of dimers in the multidimeric SP-B complex is not known [35, 37]. To 
account for this diversity and uncertainty, in our simulation work we focused on hexamers 
(see comparison of oligomer sizes in Fig. S17). This decision was based on both feasibility of 
the structure, the size of the simulation systems, and the point that hexamers fit well into the 
electron microscopy density described further by Olmeda et al. [35]. 
The disulfide-bridged dimer models. The models of the disulfide bridged dimer were 
generated by extracting two neighboring monomers connected by the interchain disulfide 
bond at C48 from the hexameric oligomer constructed as described above. 
5.2. Coarse-grained MD Simulations 
Coarse-grained MD simulations of the aforementioned oligomeric states of SP-B were 
performed in three different environments: lipid dispersion (self-assembly), bilayers, and 
monolayers (see below for detailed descriptions). Table 1 lists all studied lipid compositions.  
Simulation Protocols. The CG non-polarizable Martini model version 2.2 [46, 48, 49] with 
the “newRF” parameters described by de Jong et al. [72] was employed, unless mentioned 
otherwise. The coarse-grained protein models were built from the aforementioned all-atom 
models using martinize.py (version 2.2) [46]. All CG protein models used in the simulations 
described below were based on the closed SP-B conformation. The protonation state of each 
residue was assigned based on its pKa in aqueous solution at pH 7. An elastic network with 
the default options [73] was used to preserve the secondary and tertiary structures of the 
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proteins. More precisely, the elastic bond force constant was 500 kJ mol
-1
 nm
-2
 and the cutoff 
distance (RC) was 0.9 nm. For supradimeric oligomers, elastic network bonds between the 
subunits connected by the inter-chain disulfide bridges were removed to allow reorientation of 
the subunits, and to account for some conformational flexibility of the oligomers. The elastic 
network is used to preserve higher-order structure of proteins in the Martini model [46], but it 
also restricts the protein from changing conformation from e.g. between the suggested open 
and closed conformation of SP-B. We concentrated on the closed conformation, as discussed 
above. 
All simulations were performed using the Gromacs 5.1.x software package [74] with an 
integration time step of 25 fs. Coulombic interactions were calculated using the reaction-field 
algorithm [75] with r = 15 and rf = . The Verlet [76] cut-off scheme was employed for the 
non-bonded interactions with a LJ cutoff (for Lennard-Jones interactions) of 1.1 nm. The 
temperature was controlled using the stochastic velocity rescaling thermostat [77] with the 
protein, lipids, and solvent (water and ions) coupled to separate heat baths each at 310 K with 
a time constant of 1.0 ps. For pressure coupling, the Parrinello-Rahman barostat [78] was 
employed, unless otherwise stated. The self-assembly and the bilayer simulations were 
performed in the NpT ensemble with isotropic and semi-isotropic pressure coupling, 
respectively, with the reference pressure set to 1 bar and the time constant to 12 ps. The 
monolayer simulations were performed in the NVT ensemble. Periodic boundary conditions 
were used in all dimensions. 
The refined polarizable Martini water model with the “newPME” parameters described by 
Michalowsky et al. [47] (together with PME) was used in a subset of the bilayer simulations. 
This improved water model with the new parameters suited for PME electrostatics provides 
more precise long-range electrostatics in Martini simulations. The newPME parameters are 
identical to the newRF ones, with the exception of using the smooth Particle-Mesh-Ewald 
(PME) method [79]. As with the standard polarizable Martini water model [80], r = 2.5. The 
LINCS [81] algorithm was used to constrain all bond lengths within the water beads. 
5.3. Lipid Self-Assembly Simulations 
Separate lipid self-assembly simulations were performed to investigate the spontaneous 
assembly of lipids around all SP-B models: SP-B disulfide-bridged dimer, SP-B functional 
dimer, and the SP-B hexamer. For each protein, four different lipid compositions were 
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considered (see Table 1): DPPC-CHOL, equimolar (EQUI), no cholesterol (NoCHOL), and 
physiological (PHYSIOL). The simulations were initiated with lipids placed randomly in the 
simulation box with the protein in the center. No lipids were placed in the putative lipid 
binding pockets of the SP-B functional dimer or the SP-B hexamer prior to any of the 
simulations. The number of lipids for self-assembly was chosen based on the size of the 
protein (300, 600, 600, and 1100, respectively). The systems were solvated with 20 water 
beads per lipid, except for the hexamer system, where 30 water beads per lipid were added. 
Ions were added to attain a physiological salt concentration of 0.15 M of NaCl in addition to 
those needed for neutralizing the systems. For each lipid-protein composition, 24 self-
assembly simulations, each 2.5 s long, were performed (4 proteins  4 lipid compositions  
24  2.5 s = 960 s in total). The self-assembly simulations were performed with isotropic 
pressure control. See Table S1 (in Supporting Information (SI)) for the detailed composition 
of each system. 
5.4. Bilayer Simulations 
First, a bilayer consisting of a total of 880 lipids with the PHYSIOL composition and 20 
water beads per lipid was built using insane.py [82] and simulated for 20 ns. Using this 
configuration, another bilayer with the NoPG composition was prepared by substituting the 
POPG molecules in the PHYSIOL bilayer with POPC. Both bilayers were then equilibrated 
for another 20 ns. SP-B hexamer was next added to each bilayer system such that its distance 
to each leaflet was 9 nm and the axis of its central pore was parallel to the membrane normal. 
After solvation (~43 water beads per lipid) and addition of neutralizing ions (see Table S2), 
the systems were energy minimized and equilibrated with the protein restrained for 20 ns. 
After equilibration, 24 repetitions were simulated for 40 µs each, using both PHYSIOL and 
NoPG compositions (2  24  40 µs in total). The production simulations of the bilayer 
systems were performed with semi-isotropic pressure control. 
The same equilibrated bilayer constructions with the SP-B hexamer, as described below, were 
used as a basis of the polarizable water model systems. The standard water beads were 
replaced with the three-point water beads, the systems were then minimized and equilibrated 
for 20 ns, as described above. After equilibration, 3 repetitions were simulated for 2.5 µs 
each, using both PHYSIOL and NoPG compositions. 
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5.5. Monolayer Simulations 
The interaction of the SP-B hexamer with monolayers were studied using three different lipid 
compositions (PHYSIOL, NoPG, NoCHOL; see Table 1). The monolayers were prepared 
from bilayers of the same composition by separating the leaflets. The box dimension along 
the monolayer normal (z) was set to 20 nm to prevent interactions through the vacuum, which 
was used to mimic the air–water interface of the alveoli. To maintain the vacuum between the 
monolayers, all monolayer simulations were performed in the NVT ensemble with the box 
dimensions along the membrane plane set to achieve two different initial area per lipid (APL) 
values for each lipid composition: 55 or 57.5 Å
2
. The protein was added to the monolayer 
systems such that the axis of the central pore was parallel to the monolayer normal and the 
protein was in contact with both monolayers. To investigate the effect of hydration (i.e. 
monolayer distance), we placed a different number of water molecules between the leaflets: 
4000, 4500, 5000, or 5500 water beads for the APL of 55 Å
2
, and 4500, 5000, 5500, or 6000 
water beads for the APL of 57.5 Å
2
. For each system, three repetitions were run for 25 µs (75 
µs for each lipid composition and number-of-water-beads combinations; 1800 µs in total; see 
Table S3). 
5.6. Analysis 
Residue-specific lipid interaction. The lipid contact occupancy with SP-B was calculated by 
counting the times a given type of lipid was within a distance of 6 Å from a specific residue in 
a trajectory, and then normalized by the number of each repeating residue and number of 
frames. For the dimer structures the residues repeat twice, while in the SP-B hexamer each 
residue repeats twelve times. The first 500 ns of the trajectories were omitted from the 
analysis. The distance of a residue from the center of the SP-B hexamer was calculated from 
the structure shown in Fig. 1G and is depicted to indicate the approximate relative position of 
each residue in SP-B.  
Rate of membrane adsorption. The number of contacts between the protein and the lipids 
were calculated using the gmx mindist tool with a cutoff of 6 Å. The time required for 
membrane binding was determined based on the number of contacts, and calculated by 
averaging over all 24 repetitions in both lipid compositions. The last 500 ns of the trajectory 
was used to determine the number of dimers in the hexamer in contact with the membrane. 
One dimer corresponds to approximately 200 protein–lipid contacts. 
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Lateral lipid reorganization. The two-dimensional number density for each lipid type in the 
monolayer systems was calculated with the gmx densmap tool. The first 500 ns of the 
trajectories were omitted from the analysis. Results were normalized per relative lipid 
composition and averaged over 12 parallel repetitions at a given APL. 
Lipid protrusion. The protrusion of lipids from the monolayer into the central pore of the 
hexamer ring was evaluated by calculating the difference in the z direction between the lipids 
in or near the central pore and the lipids around the protein. Results were averaged over the 
systems with the same lipid composition at both APLs. 
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Jesús Pérez-Gil: Conceptualization, Writing – Review & Editing, Funding acquisition  
Ilpo Vattulainen: Conceptualization, Validation, Resources, Writing - Original Draft, 
Supervision, Project administration, Funding acquisition  
 
  
Journal Pre-proof
Jo
urn
al 
Pr
e-p
roo
f
 36 
System DPPC POPC POPG CHOL 
DPPC-CHOL 90   10 
EQUI 25 25 25 25 
NoPG 50 40  10 
NoCHOL 55.6 27.7 16.7  
PHYSIOL 50 25 15 10 
 
Table 1: The lipid compositions (in units of mol-%) used in this study. “DPPC-CHOL” 
consists of DPPC and CHOL. “EQUI” refers to an equimolar mixture of the four different 
lipid components: DPPC, CHOL, palmitoyl-oleoyl-PC (POPC), and palmitoyl-oleoyl-PG 
(POPG).  “NoPG” has no PG, “NoCHOL” has no CHOL, and “PHYSIOL” describes a 
physiological mixture in terms of these four lipids. 
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Pulmonary Surfactant Lipid Reorganization Induced by the 
Adsorption of the Oligomeric Surfactant Protein B Complex 
Highlights 
 Surfactant Protein B (SP-B) is arranged as an oligomer of at least six homo-dimers 
 SP-B oligomer induces formation of monolayer perturbations in lung surfactant 
 Anionic surfactant lipids increase the efficacy of SP-B in lipid transfer 
 Cholesterol binds to specific high-affinity interaction sites on the SP-B oligomer 
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